Halcion (Triazolam)

Halcion (triazolam) is an oral benzodiazepine medication used in the European market. It belongs to the sedative‑hypnotic therapeutic class and acts as a positive allosteric modulator of the GABA‑A receptor. The drug is prescribed by healthcare professionals for short‑term management of sleep disturbances and is available only with a prescription.

Halcion is indicated for the short‑term treatment of insomnia, particularly when difficulty falling asleep is the primary complaint. It may be considered in patients who need rapid onset of sleep and have no contraindications to benzodiazepine therapy.

- Short‑term relief of difficulty initiating sleep - Management of transient insomnia associated with stress or jet lag - Use in adults when non‑pharmacologic measures are insufficient - May be prescribed for occasional sleep disruption in controlled settings - Not intended for chronic insomnia without specialist oversight

Side effects of Halcion vary in frequency and severity. Common reactions are usually mild and transient, while serious effects require immediate medical attention.

Common: - Drowsiness or fatigue - Dizziness or light‑headedness - Headache - Impaired coordination or balance - Memory disturbances (anterograde amnesia) - Gastrointestinal upset (nausea, constipation)

Serious: - Respiratory depression - Severe allergic reaction (rash, swelling, difficulty breathing) - Paradoxical agitation or aggression - Dependence or withdrawal symptoms - Mood changes (depression, suicidal thoughts) - Hallucinations or psychotic symptoms

Before starting Halcion, several safety considerations should be reviewed to minimize risk. Patients and prescribers should assess the following factors.

- History of substance abuse, dependence, or withdrawal risk - Presence of respiratory disorders such as COPD or sleep apnea - Concomitant use of other central nervous system depressants - Pregnancy, lactation, or plans to become pregnant - Elderly patients who may be more sensitive to sedation and falls - Liver or kidney impairment that could affect drug clearance

Halcion can interact with a range of medications, influencing its sedative effect or increasing the risk of adverse outcomes. Interaction categories are outlined below.

Avoid: - Other benzodiazepines or barbiturates - Opioids (e.g., morphine, oxycodone) - Alcohol or recreational CNS depressants - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole)

Use with caution: - Antidepressants (especially SSRIs and SNRIs) - Antihistamines and first‑generation antihistamines - Anticonvulsants (e.g., carbamazepine) - Certain antihypertensives that may enhance hypotension